A study of 50 cases of locally advanced breast cancer relating PGP expression and response to neoadjuvant chemotherapy [53] suggests that PGP expression at diagnosis may predict a poor clinical response to neoadjuvant chemotherapy. Here, PGP is linked to breast cancer.